Cargando…
New generations of dihydropyridines for treatment of hypertension
Since the calcium channel blocker (CCB) has become one of the most prescribed agents for antihypertensive monotherapy in the world, this brief review will focus on the recent research and development of the dihydropyridine (DHP) CCB, addressing pharmacological mechanisms for the clinical efficacy of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329735/ https://www.ncbi.nlm.nih.gov/pubmed/28270844 http://dx.doi.org/10.11909/j.issn.1671-5411.2017.01.006 |